KPC Pharmaceuticals, Inc. News

KPC Pharmaceuticals, Inc.: Notice of Implementation of Annual Equity Distribution of KPC Pharmaceuticals, Inc. in 2023

Jul 23 00:00

Kunyao Group: Kunyao Group\'s 2021 Annual Equity Distribution Implementation Notice

May 24, 2022 00:00

Kunming Pharmaceutical Group 2021 Annual Equity Distribution Implementation Notice

May 24, 2022 00:00

Kunyaku Group: Kunyaku Group's announcement on the 2021 profit distribution plan

Mar 19, 2022 00:00

Kunyao Group: Kunyao Group\'s announcement on the completion of payment of the first instalment of ultra-short-term financing notes in 2021

Jul 21, 2021 00:00

Kunming Pharmaceutical Group: Kunyao Group's announcement on the issuance of the first instalment of ultra-short-term financing notes in 2021

Apr 23, 2021 00:00

Kunyao Group: Kunyao Group's announcement on the transfer of part of the shares of participating companies

Mar 16, 2021 00:00

Kunming Pharmaceutical Group: Announcement on the Feasibility Analysis Report on the Use of Funds Raised by the Public Issuance of Convertible Corporate Bonds (Second Revised Edition)

Jun 6, 2020 00:00

Kunming Pharmaceutical Group: Announcement on the Company's Plan for the Public Issuance of Convertible Corporate Bonds (Second Revised Draft)

Jun 6, 2020 00:00

Kunming Pharmaceutical Group: Announcement on the revised instructions for the company's public issuance of convertible corporate bonds

Jun 6, 2020 00:00

Kunyao Group: Announcement on the impact of the public issuance of convertible corporate bonds and diluted immediate returns on the company's main financial indicators and compensation measures and related entities' commitments (second revised draft)

Jun 6, 2020 00:00

Kunyao Group: Announcement on Extending the Validity Period of Shareholders' Meeting Resolutions and Authorizations for the Public Issuance of Convertible Corporate Bonds

Mar 31, 2020 00:00

Kunming Pharmaceutical Group: Announcement on Intended Registration and Issuance of Ultra-Short-Term Financing Notes

Mar 24, 2020 00:00

Kunming Pharmaceutical Group: Notice on Response to Feedback on Application Documents for Public Issuance of Convertible Bonds (Revised Draft)

Dec 11, 2019 00:00

Kunyao Group: 2015 Early Delisting Notice for Corporate Bonds

Sep 19, 2019 00:00

Kunming Pharmaceutical Group: Announcement on Responding to Feedback on Application Documents for the Public Issuance of Convertible Bonds

Sep 11, 2019 00:00

Kunming Pharmaceutical Group: Notice on Receiving the “China Securities Regulatory Commission Administrative Licensing Project Review Once Feedback Notice”

Aug 20, 2019 00:00

Kunming Pharmaceutical Group: Supplemental Announcement on the Acquisition of 30% of “Beck Norton (Zhejiang) Pharmaceutical Co., Ltd.” by Kunming Beck Norton Pharmaceutical Co., Ltd., a subsidiary of Kunming Pharmaceutical Group

Aug 16, 2019 00:00

Kunyao Group: Announcement on the acceptance of the application for the public issuance of convertible corporate bonds by the China Securities Regulatory Commission

Jul 9, 2019 00:00

Kunming Pharmaceutical Group: Announcement on the acquisition of 18% of the shares of “Yuxi Kunyao Commercial Fumantang Pharmaceutical Co., Ltd.”

May 23, 2019 00:00